Susceptibility to epitope specific immunotherapy of rheumatoid arthritis relies on the expression of co-stimulatory molecules associated with T cell anergy and tolerance

被引：0
|
作者：
van den Broek, Theo [1 ]
Keogh, Elissa [2 ]
van Wijk, Femke [2 ]
Ghahramani, Negar [2 ]
Schechter, Nicole [1 ]
van de Ven, Annick A. J. M. [3 ]
Albani, Salvatore [1 ]
机构：
[1] Univ Arizona, Arizona Arthritis Ctr, Tucson, AZ USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Univ Med Ctr Utrecht, Dept Pediat Immunol, Wilhelmina Childrens Hosp Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S845 / S846
页数：2
相关论文
共 50 条
  • [1] Susceptibility to epitope specific immunotherapy of rheumatoid arthritis relies on the expression of co-stimulatory molecules associated with T cell anergy and tolerance
    van den Broek, Theo
    Keogh, Elissa
    van Wiik, Fernke
    Ghahramani, Negar
    van de Ven, Annick
    Albani, Salvatore
    CLINICAL IMMUNOLOGY, 2008, 127 : S86 - S86
  • [2] Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions
    Singh, Avadhesh Kumar
    Gaur, Poonam
    Das, Satya N.
    HUMAN IMMUNOLOGY, 2014, 75 (03) : 250 - 260
  • [3] Co-stimulatory and adhesion molecules of dendritic cells in rheumatoid arthritis
    Balanescu, A
    Radu, E
    Nat, R
    Regalia, T
    Bonjinca, V
    Predescu, V
    Predeteanu, D
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2002, 6 (03) : 415 - 425
  • [4] Epitope-Specific Immunotherapy of Rheumatoid Arthritis Clinical Responsiveness Occurs With Immune Deviation and Relies on the Expression of a Cluster of Molecules Associated With T Cell Tolerance in a Double-Blind, Placebo-Controlled, Pilot Phase II Trial
    Koffeman, Eva C.
    Genovese, Mark
    Amox, Diane
    Keogh, Elissa
    Santana, Ernesto
    Matteson, Eric L.
    Kavanaugh, Arthur
    Molitor, Jerry A.
    Schiff, Michael H.
    Posever, James O.
    Bathon, Joan M.
    Kivitz, Alan J.
    Samodal, Rodrigo
    Belardi, Francis
    Dennehey, Carolyn
    van den Broek, Theo
    van Wijk, Femke
    Zhang, Xiao
    Zieseniss, Peter
    Le, Tho
    Prakken, Berent A.
    Cutter, Gary C.
    Albani, Salvatore
    ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3207 - 3216
  • [5] Role of Co-stimulatory Molecules in T Helper Cell Differentiation
    Schorer, Michelle
    Kuchroo, Vijay K.
    Joller, Nicole
    CO-SIGNAL MOLECULES IN T CELL ACTIVATION: IMMUNE REGULATION IN HEALTH AND DISEASE, 2019, 1189 : 153 - 177
  • [6] Regulation of T-cell migration by co-stimulatory molecules
    David, R.
    Marelli-Berg, F. M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1114 - 1118
  • [7] Differential expression of co-stimulatory molecules on PBMCs from patients with active systemic lupus erythematosus and rheumatoid arthritis
    Rojas-Ramos, E
    Martinez-Jimenez, NE
    Garfias, YB
    Zenteno, EG
    Lascurain, RL
    CLINICAL IMMUNOLOGY, 2005, 115 : S103 - S103
  • [8] Acidosis regulates immune progression in rheumatoid arthritis by promoting the expression of cytokines and co-stimulatory molecules in synovial fibroblasts
    Xuewen Qian
    Zhuoyan Zai
    Yuemin Tao
    Huifang Lv
    Mengjia Hao
    Longbiao Zhang
    Xiaoyue Zhang
    Yayun Xu
    Yihao Zhang
    Feihu Chen
    Molecular Medicine, 31 (1)
  • [9] Role of co-stimulatory molecules in macrophage regulation of T cell activation
    Riggs, James
    Bartlett, Tom
    Silberman, Dan
    Composto, Gabriella
    Werda, Amy
    Cua, Jackelyn
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [10] Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?
    Caporali, Roberto
    Bugatti, Serena
    Cavagna, Lorenzo
    Antivalle, Marco
    Sarzi-Puttini, Piercarlo
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 49 - 53
12345